nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—OPRD1—coronary artery disease	0.437	1	CbGaD
Hydrocodone—CYP3A4—Ticagrelor—coronary artery disease	0.0276	0.0901	CbGbCtD
Hydrocodone—CYP3A4—Fenofibrate—coronary artery disease	0.0246	0.0803	CbGbCtD
Hydrocodone—CYP2D6—Niacin—coronary artery disease	0.0203	0.0664	CbGbCtD
Hydrocodone—CYP3A4—Gemfibrozil—coronary artery disease	0.0197	0.0642	CbGbCtD
Hydrocodone—CYP2D6—Timolol—coronary artery disease	0.0189	0.0617	CbGbCtD
Hydrocodone—CYP3A4—Clopidogrel—coronary artery disease	0.0171	0.0557	CbGbCtD
Hydrocodone—CYP2D6—Captopril—coronary artery disease	0.0166	0.0543	CbGbCtD
Hydrocodone—CYP2D6—Simvastatin—coronary artery disease	0.0161	0.0525	CbGbCtD
Hydrocodone—CYP3A4—Eplerenone—coronary artery disease	0.0159	0.0518	CbGbCtD
Hydrocodone—CYP2D6—Pravastatin—coronary artery disease	0.0157	0.0513	CbGbCtD
Hydrocodone—CYP2D6—Lovastatin—coronary artery disease	0.0157	0.0513	CbGbCtD
Hydrocodone—CYP2D6—Atorvastatin—coronary artery disease	0.0143	0.0468	CbGbCtD
Hydrocodone—CYP3A4—Enalapril—coronary artery disease	0.0141	0.0461	CbGbCtD
Hydrocodone—CYP3A4—Ezetimibe—coronary artery disease	0.011	0.0359	CbGbCtD
Hydrocodone—CYP3A4—Rosuvastatin—coronary artery disease	0.011	0.0359	CbGbCtD
Hydrocodone—CYP3A4—Simvastatin—coronary artery disease	0.0102	0.0334	CbGbCtD
Hydrocodone—CYP3A4—Pravastatin—coronary artery disease	0.01	0.0326	CbGbCtD
Hydrocodone—CYP3A4—Lovastatin—coronary artery disease	0.01	0.0326	CbGbCtD
Hydrocodone—CYP3A4—Atorvastatin—coronary artery disease	0.00911	0.0297	CbGbCtD
Hydrocodone—CYP3A4—Losartan—coronary artery disease	0.00833	0.0272	CbGbCtD
Hydrocodone—Naloxone—CREB1—coronary artery disease	0.00079	0.164	CrCbGaD
Hydrocodone—Heroin—OPRD1—coronary artery disease	0.000636	0.132	CrCbGaD
Hydrocodone—Levorphanol—OPRD1—coronary artery disease	0.000499	0.103	CrCbGaD
Hydrocodone—Naltrexone—OPRD1—coronary artery disease	0.000423	0.0875	CrCbGaD
Hydrocodone—Oxymorphone—OPRD1—coronary artery disease	0.000423	0.0875	CrCbGaD
Hydrocodone—Oxycodone—OPRD1—coronary artery disease	0.000337	0.0698	CrCbGaD
Hydrocodone—Codeine—OPRD1—coronary artery disease	0.000322	0.0666	CrCbGaD
Hydrocodone—Naloxone—OPRD1—coronary artery disease	0.000308	0.0638	CrCbGaD
Hydrocodone—Hydromorphone—OPRD1—coronary artery disease	0.000306	0.0634	CrCbGaD
Hydrocodone—Morphine—OPRD1—coronary artery disease	0.00026	0.0539	CrCbGaD
Hydrocodone—Dextromethorphan—OPRD1—coronary artery disease	0.000219	0.0453	CrCbGaD
Hydrocodone—Naloxone—ESR1—coronary artery disease	0.000154	0.0318	CrCbGaD
Hydrocodone—Muscle spasms—Lisinopril—coronary artery disease	0.000115	0.000665	CcSEcCtD
Hydrocodone—Constipation—Perindopril—coronary artery disease	0.000114	0.000661	CcSEcCtD
Hydrocodone—Vomiting—Fenofibrate—coronary artery disease	0.000114	0.000661	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000114	0.000661	CcSEcCtD
Hydrocodone—Hypersensitivity—Valsartan—coronary artery disease	0.000114	0.000661	CcSEcCtD
Hydrocodone—Convulsion—Ramipril—coronary artery disease	0.000114	0.00066	CcSEcCtD
Hydrocodone—Body temperature increased—Trandolapril—coronary artery disease	0.000114	0.000659	CcSEcCtD
Hydrocodone—Abdominal pain—Trandolapril—coronary artery disease	0.000114	0.000659	CcSEcCtD
Hydrocodone—Dizziness—Ezetimibe—coronary artery disease	0.000114	0.000659	CcSEcCtD
Hydrocodone—Body temperature increased—Enalapril—coronary artery disease	0.000113	0.000657	CcSEcCtD
Hydrocodone—Abdominal pain—Enalapril—coronary artery disease	0.000113	0.000657	CcSEcCtD
Hydrocodone—Insomnia—Losartan—coronary artery disease	0.000113	0.000656	CcSEcCtD
Hydrocodone—Rash—Fenofibrate—coronary artery disease	0.000113	0.000656	CcSEcCtD
Hydrocodone—Dermatitis—Fenofibrate—coronary artery disease	0.000113	0.000655	CcSEcCtD
Hydrocodone—Headache—Fenofibrate—coronary artery disease	0.000112	0.000651	CcSEcCtD
Hydrocodone—Paraesthesia—Losartan—coronary artery disease	0.000112	0.000651	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Captopril—coronary artery disease	0.000112	0.000651	CcSEcCtD
Hydrocodone—Cough—Timolol—coronary artery disease	0.000112	0.00065	CcSEcCtD
Hydrocodone—Vomiting—Clopidogrel—coronary artery disease	0.000112	0.00065	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000112	0.000649	CcSEcCtD
Hydrocodone—Arthralgia—Ramipril—coronary artery disease	0.000112	0.000649	CcSEcCtD
Hydrocodone—Myalgia—Ramipril—coronary artery disease	0.000112	0.000649	CcSEcCtD
Hydrocodone—Fatigue—Furosemide—coronary artery disease	0.000112	0.000648	CcSEcCtD
Hydrocodone—Tremor—Lisinopril—coronary artery disease	0.000112	0.000648	CcSEcCtD
Hydrocodone—Abdominal pain—Telmisartan—coronary artery disease	0.000112	0.000648	CcSEcCtD
Hydrocodone—Body temperature increased—Telmisartan—coronary artery disease	0.000112	0.000648	CcSEcCtD
Hydrocodone—Dyspnoea—Losartan—coronary artery disease	0.000112	0.000647	CcSEcCtD
Hydrocodone—Anxiety—Ramipril—coronary artery disease	0.000112	0.000647	CcSEcCtD
Hydrocodone—Vomiting—Lovastatin—coronary artery disease	0.000111	0.000646	CcSEcCtD
Hydrocodone—Somnolence—Losartan—coronary artery disease	0.000111	0.000645	CcSEcCtD
Hydrocodone—Dizziness—Eplerenone—coronary artery disease	0.000111	0.000645	CcSEcCtD
Hydrocodone—Rash—Clopidogrel—coronary artery disease	0.000111	0.000645	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000111	0.000644	CcSEcCtD
Hydrocodone—Dermatitis—Clopidogrel—coronary artery disease	0.000111	0.000644	CcSEcCtD
Hydrocodone—Asthenia—Valsartan—coronary artery disease	0.000111	0.000644	CcSEcCtD
Hydrocodone—Constipation—Furosemide—coronary artery disease	0.000111	0.000643	CcSEcCtD
Hydrocodone—Hypersensitivity—Niacin—coronary artery disease	0.000111	0.000643	CcSEcCtD
Hydrocodone—Asthenia—Olmesartan—coronary artery disease	0.00011	0.00064	CcSEcCtD
Hydrocodone—Headache—Clopidogrel—coronary artery disease	0.00011	0.00064	CcSEcCtD
Hydrocodone—Rash—Lovastatin—coronary artery disease	0.00011	0.00064	CcSEcCtD
Hydrocodone—Dermatitis—Lovastatin—coronary artery disease	0.00011	0.00064	CcSEcCtD
Hydrocodone—Headache—Lovastatin—coronary artery disease	0.00011	0.000636	CcSEcCtD
Hydrocodone—Pruritus—Valsartan—coronary artery disease	0.000109	0.000635	CcSEcCtD
Hydrocodone—Dry mouth—Ramipril—coronary artery disease	0.000109	0.000635	CcSEcCtD
Hydrocodone—Myalgia—Timolol—coronary artery disease	0.000109	0.000634	CcSEcCtD
Hydrocodone—Arthralgia—Timolol—coronary artery disease	0.000109	0.000634	CcSEcCtD
Hydrocodone—Vomiting—Ezetimibe—coronary artery disease	0.000109	0.000633	CcSEcCtD
Hydrocodone—Hypersensitivity—Pravastatin—coronary artery disease	0.000109	0.000633	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Perindopril—coronary artery disease	0.000109	0.000632	CcSEcCtD
Hydrocodone—Anxiety—Timolol—coronary artery disease	0.000109	0.000632	CcSEcCtD
Hydrocodone—Pruritus—Olmesartan—coronary artery disease	0.000109	0.000632	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000109	0.00063	CcSEcCtD
Hydrocodone—Abdominal pain—Captopril—coronary artery disease	0.000109	0.00063	CcSEcCtD
Hydrocodone—Body temperature increased—Captopril—coronary artery disease	0.000109	0.00063	CcSEcCtD
Hydrocodone—Dizziness—Simvastatin—coronary artery disease	0.000108	0.000628	CcSEcCtD
Hydrocodone—Rash—Ezetimibe—coronary artery disease	0.000108	0.000628	CcSEcCtD
Hydrocodone—Dermatitis—Ezetimibe—coronary artery disease	0.000108	0.000627	CcSEcCtD
Hydrocodone—Asthenia—Niacin—coronary artery disease	0.000108	0.000626	CcSEcCtD
Hydrocodone—Fatigue—Losartan—coronary artery disease	0.000108	0.000625	CcSEcCtD
Hydrocodone—Headache—Ezetimibe—coronary artery disease	0.000108	0.000624	CcSEcCtD
Hydrocodone—Dry mouth—Timolol—coronary artery disease	0.000107	0.00062	CcSEcCtD
Hydrocodone—Constipation—Losartan—coronary artery disease	0.000107	0.00062	CcSEcCtD
Hydrocodone—Vomiting—Eplerenone—coronary artery disease	0.000107	0.00062	CcSEcCtD
Hydrocodone—Nausea—Fenofibrate—coronary artery disease	0.000107	0.000618	CcSEcCtD
Hydrocodone—Pruritus—Niacin—coronary artery disease	0.000106	0.000617	CcSEcCtD
Hydrocodone—Asthenia—Pravastatin—coronary artery disease	0.000106	0.000616	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Furosemide—coronary artery disease	0.000106	0.000615	CcSEcCtD
Hydrocodone—Rash—Eplerenone—coronary artery disease	0.000106	0.000615	CcSEcCtD
Hydrocodone—Hypersensitivity—Trandolapril—coronary artery disease	0.000106	0.000614	CcSEcCtD
Hydrocodone—Dermatitis—Eplerenone—coronary artery disease	0.000106	0.000614	CcSEcCtD
Hydrocodone—Hypersensitivity—Enalapril—coronary artery disease	0.000106	0.000612	CcSEcCtD
Hydrocodone—Body temperature increased—Perindopril—coronary artery disease	0.000105	0.000611	CcSEcCtD
Hydrocodone—Abdominal pain—Perindopril—coronary artery disease	0.000105	0.000611	CcSEcCtD
Hydrocodone—Headache—Eplerenone—coronary artery disease	0.000105	0.000611	CcSEcCtD
Hydrocodone—Nervous system disorder—Ramipril—coronary artery disease	0.000105	0.00061	CcSEcCtD
Hydrocodone—Thrombocytopenia—Ramipril—coronary artery disease	0.000105	0.000609	CcSEcCtD
Hydrocodone—Pruritus—Pravastatin—coronary artery disease	0.000105	0.000608	CcSEcCtD
Hydrocodone—Nausea—Clopidogrel—coronary artery disease	0.000105	0.000607	CcSEcCtD
Hydrocodone—Skin disorder—Ramipril—coronary artery disease	0.000104	0.000604	CcSEcCtD
Hydrocodone—Vomiting—Simvastatin—coronary artery disease	0.000104	0.000604	CcSEcCtD
Hydrocodone—Hypersensitivity—Telmisartan—coronary artery disease	0.000104	0.000604	CcSEcCtD
Hydrocodone—Cough—Lisinopril—coronary artery disease	0.000104	0.000603	CcSEcCtD
Hydrocodone—Nausea—Lovastatin—coronary artery disease	0.000104	0.000603	CcSEcCtD
Hydrocodone—Hyperhidrosis—Ramipril—coronary artery disease	0.000104	0.000601	CcSEcCtD
Hydrocodone—Rash—Simvastatin—coronary artery disease	0.000103	0.000599	CcSEcCtD
Hydrocodone—Dermatitis—Simvastatin—coronary artery disease	0.000103	0.000598	CcSEcCtD
Hydrocodone—Asthenia—Trandolapril—coronary artery disease	0.000103	0.000598	CcSEcCtD
Hydrocodone—Nervous system disorder—Timolol—coronary artery disease	0.000103	0.000596	CcSEcCtD
Hydrocodone—Asthenia—Enalapril—coronary artery disease	0.000103	0.000596	CcSEcCtD
Hydrocodone—Headache—Simvastatin—coronary artery disease	0.000103	0.000595	CcSEcCtD
Hydrocodone—Abdominal pain—Furosemide—coronary artery disease	0.000103	0.000594	CcSEcCtD
Hydrocodone—Body temperature increased—Furosemide—coronary artery disease	0.000103	0.000594	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Losartan—coronary artery disease	0.000102	0.000593	CcSEcCtD
Hydrocodone—Dizziness—Valsartan—coronary artery disease	0.000102	0.000593	CcSEcCtD
Hydrocodone—Nausea—Ezetimibe—coronary artery disease	0.000102	0.000592	CcSEcCtD
Hydrocodone—Skin disorder—Timolol—coronary artery disease	0.000102	0.000591	CcSEcCtD
Hydrocodone—Dizziness—Olmesartan—coronary artery disease	0.000102	0.00059	CcSEcCtD
Hydrocodone—Pruritus—Trandolapril—coronary artery disease	0.000102	0.00059	CcSEcCtD
Hydrocodone—Arthralgia—Lisinopril—coronary artery disease	0.000101	0.000588	CcSEcCtD
Hydrocodone—Myalgia—Lisinopril—coronary artery disease	0.000101	0.000588	CcSEcCtD
Hydrocodone—Hyperhidrosis—Timolol—coronary artery disease	0.000101	0.000588	CcSEcCtD
Hydrocodone—Asthenia—Telmisartan—coronary artery disease	0.000101	0.000588	CcSEcCtD
Hydrocodone—Pruritus—Enalapril—coronary artery disease	0.000101	0.000588	CcSEcCtD
Hydrocodone—Anxiety—Lisinopril—coronary artery disease	0.000101	0.000586	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000101	0.000584	CcSEcCtD
Hydrocodone—Hypotension—Ramipril—coronary artery disease	0.0001	0.000581	CcSEcCtD
Hydrocodone—Pruritus—Telmisartan—coronary artery disease	0.0001	0.00058	CcSEcCtD
Hydrocodone—Nausea—Eplerenone—coronary artery disease	9.99e-05	0.000579	CcSEcCtD
Hydrocodone—Dizziness—Niacin—coronary artery disease	9.95e-05	0.000577	CcSEcCtD
Hydrocodone—Dry mouth—Lisinopril—coronary artery disease	9.93e-05	0.000576	CcSEcCtD
Hydrocodone—Body temperature increased—Losartan—coronary artery disease	9.89e-05	0.000573	CcSEcCtD
Hydrocodone—Abdominal pain—Losartan—coronary artery disease	9.89e-05	0.000573	CcSEcCtD
Hydrocodone—Asthenia—Captopril—coronary artery disease	9.86e-05	0.000572	CcSEcCtD
Hydrocodone—Vomiting—Valsartan—coronary artery disease	9.84e-05	0.00057	CcSEcCtD
Hydrocodone—Hypotension—Timolol—coronary artery disease	9.8e-05	0.000568	CcSEcCtD
Hydrocodone—Dizziness—Pravastatin—coronary artery disease	9.79e-05	0.000568	CcSEcCtD
Hydrocodone—Vomiting—Olmesartan—coronary artery disease	9.79e-05	0.000568	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Ramipril—coronary artery disease	9.77e-05	0.000567	CcSEcCtD
Hydrocodone—Rash—Valsartan—coronary artery disease	9.75e-05	0.000566	CcSEcCtD
Hydrocodone—Dermatitis—Valsartan—coronary artery disease	9.74e-05	0.000565	CcSEcCtD
Hydrocodone—Nausea—Simvastatin—coronary artery disease	9.73e-05	0.000564	CcSEcCtD
Hydrocodone—Pruritus—Captopril—coronary artery disease	9.72e-05	0.000564	CcSEcCtD
Hydrocodone—Rash—Olmesartan—coronary artery disease	9.71e-05	0.000563	CcSEcCtD
Hydrocodone—Insomnia—Ramipril—coronary artery disease	9.7e-05	0.000563	CcSEcCtD
Hydrocodone—Dermatitis—Olmesartan—coronary artery disease	9.7e-05	0.000562	CcSEcCtD
Hydrocodone—Headache—Valsartan—coronary artery disease	9.69e-05	0.000562	CcSEcCtD
Hydrocodone—Headache—Olmesartan—coronary artery disease	9.64e-05	0.000559	CcSEcCtD
Hydrocodone—Paraesthesia—Ramipril—coronary artery disease	9.63e-05	0.000559	CcSEcCtD
Hydrocodone—Asthenia—Perindopril—coronary artery disease	9.57e-05	0.000555	CcSEcCtD
Hydrocodone—Dyspnoea—Ramipril—coronary artery disease	9.56e-05	0.000555	CcSEcCtD
Hydrocodone—Vomiting—Niacin—coronary artery disease	9.56e-05	0.000554	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Timolol—coronary artery disease	9.55e-05	0.000554	CcSEcCtD
Hydrocodone—Hypersensitivity—Furosemide—coronary artery disease	9.55e-05	0.000554	CcSEcCtD
Hydrocodone—Somnolence—Ramipril—coronary artery disease	9.54e-05	0.000553	CcSEcCtD
Hydrocodone—Thrombocytopenia—Lisinopril—coronary artery disease	9.53e-05	0.000552	CcSEcCtD
Hydrocodone—Dizziness—Trandolapril—coronary artery disease	9.51e-05	0.000551	CcSEcCtD
Hydrocodone—Insomnia—Timolol—coronary artery disease	9.49e-05	0.00055	CcSEcCtD
Hydrocodone—Rash—Niacin—coronary artery disease	9.48e-05	0.00055	CcSEcCtD
Hydrocodone—Dermatitis—Niacin—coronary artery disease	9.47e-05	0.000549	CcSEcCtD
Hydrocodone—Dizziness—Enalapril—coronary artery disease	9.47e-05	0.000549	CcSEcCtD
Hydrocodone—Skin disorder—Lisinopril—coronary artery disease	9.45e-05	0.000548	CcSEcCtD
Hydrocodone—Pruritus—Perindopril—coronary artery disease	9.44e-05	0.000547	CcSEcCtD
Hydrocodone—Headache—Niacin—coronary artery disease	9.42e-05	0.000546	CcSEcCtD
Hydrocodone—Paraesthesia—Timolol—coronary artery disease	9.42e-05	0.000546	CcSEcCtD
Hydrocodone—Vomiting—Pravastatin—coronary artery disease	9.42e-05	0.000546	CcSEcCtD
Hydrocodone—Hyperhidrosis—Lisinopril—coronary artery disease	9.41e-05	0.000545	CcSEcCtD
Hydrocodone—Dyspnoea—Timolol—coronary artery disease	9.35e-05	0.000542	CcSEcCtD
Hydrocodone—Dizziness—Telmisartan—coronary artery disease	9.34e-05	0.000542	CcSEcCtD
Hydrocodone—Rash—Pravastatin—coronary artery disease	9.34e-05	0.000541	CcSEcCtD
Hydrocodone—Dermatitis—Pravastatin—coronary artery disease	9.33e-05	0.000541	CcSEcCtD
Hydrocodone—Somnolence—Timolol—coronary artery disease	9.32e-05	0.000541	CcSEcCtD
Hydrocodone—Asthenia—Furosemide—coronary artery disease	9.3e-05	0.000539	CcSEcCtD
Hydrocodone—Headache—Pravastatin—coronary artery disease	9.28e-05	0.000538	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Ramipril—coronary artery disease	9.26e-05	0.000537	CcSEcCtD
Hydrocodone—Fatigue—Ramipril—coronary artery disease	9.25e-05	0.000536	CcSEcCtD
Hydrocodone—Hypersensitivity—Losartan—coronary artery disease	9.22e-05	0.000534	CcSEcCtD
Hydrocodone—Nausea—Valsartan—coronary artery disease	9.19e-05	0.000533	CcSEcCtD
Hydrocodone—Pruritus—Furosemide—coronary artery disease	9.17e-05	0.000532	CcSEcCtD
Hydrocodone—Constipation—Ramipril—coronary artery disease	9.17e-05	0.000532	CcSEcCtD
Hydrocodone—Nausea—Olmesartan—coronary artery disease	9.14e-05	0.00053	CcSEcCtD
Hydrocodone—Vomiting—Trandolapril—coronary artery disease	9.14e-05	0.00053	CcSEcCtD
Hydrocodone—Vomiting—Enalapril—coronary artery disease	9.11e-05	0.000528	CcSEcCtD
Hydrocodone—Hypotension—Lisinopril—coronary artery disease	9.09e-05	0.000527	CcSEcCtD
Hydrocodone—Dizziness—Captopril—coronary artery disease	9.08e-05	0.000527	CcSEcCtD
Hydrocodone—Rash—Trandolapril—coronary artery disease	9.07e-05	0.000526	CcSEcCtD
Hydrocodone—Dermatitis—Trandolapril—coronary artery disease	9.06e-05	0.000525	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Timolol—coronary artery disease	9.05e-05	0.000525	CcSEcCtD
Hydrocodone—Fatigue—Timolol—coronary artery disease	9.04e-05	0.000524	CcSEcCtD
Hydrocodone—Rash—Enalapril—coronary artery disease	9.03e-05	0.000524	CcSEcCtD
Hydrocodone—Dermatitis—Enalapril—coronary artery disease	9.02e-05	0.000523	CcSEcCtD
Hydrocodone—Headache—Trandolapril—coronary artery disease	9.01e-05	0.000522	CcSEcCtD
Hydrocodone—Vomiting—Telmisartan—coronary artery disease	8.98e-05	0.000521	CcSEcCtD
Hydrocodone—Asthenia—Losartan—coronary artery disease	8.98e-05	0.00052	CcSEcCtD
Hydrocodone—Headache—Enalapril—coronary artery disease	8.97e-05	0.00052	CcSEcCtD
Hydrocodone—Nausea—Niacin—coronary artery disease	8.93e-05	0.000518	CcSEcCtD
Hydrocodone—Rash—Telmisartan—coronary artery disease	8.91e-05	0.000516	CcSEcCtD
Hydrocodone—Dermatitis—Telmisartan—coronary artery disease	8.9e-05	0.000516	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Lisinopril—coronary artery disease	8.86e-05	0.000514	CcSEcCtD
Hydrocodone—Pruritus—Losartan—coronary artery disease	8.85e-05	0.000513	CcSEcCtD
Hydrocodone—Headache—Telmisartan—coronary artery disease	8.85e-05	0.000513	CcSEcCtD
Hydrocodone—Dizziness—Perindopril—coronary artery disease	8.82e-05	0.000511	CcSEcCtD
Hydrocodone—Insomnia—Lisinopril—coronary artery disease	8.8e-05	0.00051	CcSEcCtD
Hydrocodone—Nausea—Pravastatin—coronary artery disease	8.8e-05	0.00051	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Ramipril—coronary artery disease	8.77e-05	0.000509	CcSEcCtD
Hydrocodone—Dextromethorphan—CYP2C19—coronary artery disease	8.74e-05	0.0181	CrCbGaD
Hydrocodone—Paraesthesia—Lisinopril—coronary artery disease	8.74e-05	0.000507	CcSEcCtD
Hydrocodone—Vomiting—Captopril—coronary artery disease	8.73e-05	0.000506	CcSEcCtD
Hydrocodone—Dyspnoea—Lisinopril—coronary artery disease	8.67e-05	0.000503	CcSEcCtD
Hydrocodone—Rash—Captopril—coronary artery disease	8.66e-05	0.000502	CcSEcCtD
Hydrocodone—Dermatitis—Captopril—coronary artery disease	8.65e-05	0.000502	CcSEcCtD
Hydrocodone—Somnolence—Lisinopril—coronary artery disease	8.65e-05	0.000501	CcSEcCtD
Hydrocodone—Headache—Captopril—coronary artery disease	8.61e-05	0.000499	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Timolol—coronary artery disease	8.58e-05	0.000497	CcSEcCtD
Hydrocodone—Dizziness—Furosemide—coronary artery disease	8.57e-05	0.000497	CcSEcCtD
Hydrocodone—Nausea—Trandolapril—coronary artery disease	8.54e-05	0.000495	CcSEcCtD
Hydrocodone—Nausea—Enalapril—coronary artery disease	8.51e-05	0.000493	CcSEcCtD
Hydrocodone—Vomiting—Perindopril—coronary artery disease	8.48e-05	0.000492	CcSEcCtD
Hydrocodone—Body temperature increased—Ramipril—coronary artery disease	8.48e-05	0.000492	CcSEcCtD
Hydrocodone—Abdominal pain—Ramipril—coronary artery disease	8.48e-05	0.000492	CcSEcCtD
Hydrocodone—Rash—Perindopril—coronary artery disease	8.41e-05	0.000488	CcSEcCtD
Hydrocodone—Dermatitis—Perindopril—coronary artery disease	8.4e-05	0.000487	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Lisinopril—coronary artery disease	8.4e-05	0.000487	CcSEcCtD
Hydrocodone—Nausea—Telmisartan—coronary artery disease	8.39e-05	0.000487	CcSEcCtD
Hydrocodone—Fatigue—Lisinopril—coronary artery disease	8.39e-05	0.000486	CcSEcCtD
Hydrocodone—Headache—Perindopril—coronary artery disease	8.36e-05	0.000484	CcSEcCtD
Hydrocodone—Constipation—Lisinopril—coronary artery disease	8.32e-05	0.000482	CcSEcCtD
Hydrocodone—Abdominal pain—Timolol—coronary artery disease	8.29e-05	0.000481	CcSEcCtD
Hydrocodone—Body temperature increased—Timolol—coronary artery disease	8.29e-05	0.000481	CcSEcCtD
Hydrocodone—Dizziness—Losartan—coronary artery disease	8.27e-05	0.00048	CcSEcCtD
Hydrocodone—Vomiting—Furosemide—coronary artery disease	8.24e-05	0.000478	CcSEcCtD
Hydrocodone—Rash—Furosemide—coronary artery disease	8.18e-05	0.000474	CcSEcCtD
Hydrocodone—Dermatitis—Furosemide—coronary artery disease	8.17e-05	0.000474	CcSEcCtD
Hydrocodone—Nausea—Captopril—coronary artery disease	8.16e-05	0.000473	CcSEcCtD
Hydrocodone—Headache—Furosemide—coronary artery disease	8.12e-05	0.000471	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Lisinopril—coronary artery disease	7.96e-05	0.000461	CcSEcCtD
Hydrocodone—Vomiting—Losartan—coronary artery disease	7.95e-05	0.000461	CcSEcCtD
Hydrocodone—Nausea—Perindopril—coronary artery disease	7.92e-05	0.000459	CcSEcCtD
Hydrocodone—Hypersensitivity—Ramipril—coronary artery disease	7.9e-05	0.000458	CcSEcCtD
Hydrocodone—Rash—Losartan—coronary artery disease	7.89e-05	0.000457	CcSEcCtD
Hydrocodone—Dermatitis—Losartan—coronary artery disease	7.88e-05	0.000457	CcSEcCtD
Hydrocodone—Headache—Losartan—coronary artery disease	7.84e-05	0.000454	CcSEcCtD
Hydrocodone—Hypersensitivity—Timolol—coronary artery disease	7.73e-05	0.000448	CcSEcCtD
Hydrocodone—Nausea—Furosemide—coronary artery disease	7.7e-05	0.000447	CcSEcCtD
Hydrocodone—Asthenia—Ramipril—coronary artery disease	7.7e-05	0.000446	CcSEcCtD
Hydrocodone—Abdominal pain—Lisinopril—coronary artery disease	7.69e-05	0.000446	CcSEcCtD
Hydrocodone—Body temperature increased—Lisinopril—coronary artery disease	7.69e-05	0.000446	CcSEcCtD
Hydrocodone—Pruritus—Ramipril—coronary artery disease	7.59e-05	0.00044	CcSEcCtD
Hydrocodone—Asthenia—Timolol—coronary artery disease	7.52e-05	0.000436	CcSEcCtD
Hydrocodone—Nausea—Losartan—coronary artery disease	7.43e-05	0.000431	CcSEcCtD
Hydrocodone—Pruritus—Timolol—coronary artery disease	7.42e-05	0.00043	CcSEcCtD
Hydrocodone—Hypersensitivity—Lisinopril—coronary artery disease	7.17e-05	0.000416	CcSEcCtD
Hydrocodone—Dizziness—Ramipril—coronary artery disease	7.09e-05	0.000411	CcSEcCtD
Hydrocodone—Asthenia—Lisinopril—coronary artery disease	6.98e-05	0.000405	CcSEcCtD
Hydrocodone—Dizziness—Timolol—coronary artery disease	6.94e-05	0.000402	CcSEcCtD
Hydrocodone—Pruritus—Lisinopril—coronary artery disease	6.88e-05	0.000399	CcSEcCtD
Hydrocodone—Naloxone—ALB—coronary artery disease	6.84e-05	0.0142	CrCbGaD
Hydrocodone—Vomiting—Ramipril—coronary artery disease	6.82e-05	0.000395	CcSEcCtD
Hydrocodone—Rash—Ramipril—coronary artery disease	6.76e-05	0.000392	CcSEcCtD
Hydrocodone—Dermatitis—Ramipril—coronary artery disease	6.76e-05	0.000392	CcSEcCtD
Hydrocodone—Headache—Ramipril—coronary artery disease	6.72e-05	0.00039	CcSEcCtD
Hydrocodone—Vomiting—Timolol—coronary artery disease	6.67e-05	0.000387	CcSEcCtD
Hydrocodone—Rash—Timolol—coronary artery disease	6.61e-05	0.000383	CcSEcCtD
Hydrocodone—Dermatitis—Timolol—coronary artery disease	6.61e-05	0.000383	CcSEcCtD
Hydrocodone—Headache—Timolol—coronary artery disease	6.57e-05	0.000381	CcSEcCtD
Hydrocodone—Dizziness—Lisinopril—coronary artery disease	6.43e-05	0.000373	CcSEcCtD
Hydrocodone—Nausea—Ramipril—coronary artery disease	6.37e-05	0.000369	CcSEcCtD
Hydrocodone—Nausea—Timolol—coronary artery disease	6.23e-05	0.000361	CcSEcCtD
Hydrocodone—Vomiting—Lisinopril—coronary artery disease	6.19e-05	0.000359	CcSEcCtD
Hydrocodone—Rash—Lisinopril—coronary artery disease	6.13e-05	0.000356	CcSEcCtD
Hydrocodone—Dermatitis—Lisinopril—coronary artery disease	6.13e-05	0.000355	CcSEcCtD
Hydrocodone—Headache—Lisinopril—coronary artery disease	6.09e-05	0.000353	CcSEcCtD
Hydrocodone—Nausea—Lisinopril—coronary artery disease	5.78e-05	0.000335	CcSEcCtD
Hydrocodone—OPRD1—Signaling Pathways—IL6ST—coronary artery disease	8.33e-06	0.000106	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PLCB3—coronary artery disease	8.28e-06	0.000105	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NFKBIA—coronary artery disease	8.26e-06	0.000105	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APOB—coronary artery disease	8.21e-06	0.000104	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOA5—coronary artery disease	8.2e-06	0.000104	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—COX5B—coronary artery disease	8.16e-06	0.000103	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—DLAT—coronary artery disease	8.16e-06	0.000103	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTM2—coronary artery disease	8.16e-06	0.000103	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PLIN1—coronary artery disease	8.16e-06	0.000103	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PFKFB3—coronary artery disease	8.16e-06	0.000103	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CXCL8—coronary artery disease	8.14e-06	0.000103	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—JAK2—coronary artery disease	8.1e-06	0.000103	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EDN1—coronary artery disease	8.08e-06	0.000102	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—P4HB—coronary artery disease	8.04e-06	0.000102	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCL5—coronary artery disease	8.02e-06	0.000102	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KIT—coronary artery disease	8e-06	0.000101	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HIF1A—coronary artery disease	7.97e-06	0.000101	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AGT—coronary artery disease	7.94e-06	0.000101	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CSF2—coronary artery disease	7.9e-06	0.0001	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FGF1—coronary artery disease	7.9e-06	0.0001	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	7.89e-06	0.0001	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—LPL—coronary artery disease	7.84e-06	9.94e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—LEP—coronary artery disease	7.78e-06	9.86e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—APOE—coronary artery disease	7.78e-06	9.86e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RPS6KB1—coronary artery disease	7.77e-06	9.85e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MEF2C—coronary artery disease	7.77e-06	9.85e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SULT1E1—coronary artery disease	7.73e-06	9.8e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—APOA1—coronary artery disease	7.69e-06	9.75e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—GSK3B—coronary artery disease	7.68e-06	9.74e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KDR—coronary artery disease	7.62e-06	9.66e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CREB1—coronary artery disease	7.62e-06	9.66e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—POMC—coronary artery disease	7.62e-06	9.66e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ITGB3—coronary artery disease	7.57e-06	9.6e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAPK14—coronary artery disease	7.57e-06	9.6e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCL2—coronary artery disease	7.45e-06	9.45e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—VCAN—coronary artery disease	7.44e-06	9.43e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6R—coronary artery disease	7.43e-06	9.42e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ESR1—coronary artery disease	7.42e-06	9.41e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CXCL8—coronary artery disease	7.39e-06	9.37e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALDOA—coronary artery disease	7.38e-06	9.36e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AKR1B1—coronary artery disease	7.38e-06	9.35e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HK2—coronary artery disease	7.38e-06	9.35e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PPP2CA—coronary artery disease	7.36e-06	9.33e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FN1—coronary artery disease	7.33e-06	9.3e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—F2—coronary artery disease	7.33e-06	9.3e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IGF1—coronary artery disease	7.33e-06	9.29e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6ST—coronary artery disease	7.3e-06	9.26e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—MAPK1—coronary artery disease	7.29e-06	9.25e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NFKBIA—coronary artery disease	7.25e-06	9.19e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PRKCD—coronary artery disease	7.22e-06	9.16e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—DCN—coronary artery disease	7.17e-06	9.08e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC27A1—coronary artery disease	7.07e-06	8.97e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HTR2A—coronary artery disease	7.07e-06	8.96e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—C3—coronary artery disease	7.06e-06	8.95e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KIT—coronary artery disease	7.02e-06	8.9e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALDH2—coronary artery disease	6.97e-06	8.84e-05	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PIK3CA—coronary artery disease	6.97e-06	8.84e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SERPINE1—coronary artery disease	6.96e-06	8.82e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CPT1B—coronary artery disease	6.94e-06	8.79e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LCAT—coronary artery disease	6.94e-06	8.79e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOA4—coronary artery disease	6.81e-06	8.63e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—LIPC—coronary artery disease	6.79e-06	8.61e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HBA1—coronary artery disease	6.79e-06	8.61e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP2C19—coronary artery disease	6.79e-06	8.61e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	6.79e-06	8.61e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOC3—coronary artery disease	6.75e-06	8.56e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—FGF2—coronary artery disease	6.74e-06	8.54e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GSK3B—coronary artery disease	6.73e-06	8.54e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HIF1A—coronary artery disease	6.73e-06	8.54e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—LDLR—coronary artery disease	6.71e-06	8.51e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AGT—coronary artery disease	6.71e-06	8.5e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—POMC—coronary artery disease	6.68e-06	8.47e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CREB1—coronary artery disease	6.68e-06	8.47e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NOS3—coronary artery disease	6.64e-06	8.42e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTT1—coronary artery disease	6.63e-06	8.41e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SLC9A1—coronary artery disease	6.63e-06	8.41e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PDHA1—coronary artery disease	6.57e-06	8.34e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GCLM—coronary artery disease	6.57e-06	8.34e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—LEP—coronary artery disease	6.57e-06	8.33e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APOE—coronary artery disease	6.57e-06	8.33e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GCLC—coronary artery disease	6.55e-06	8.31e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CETP—coronary artery disease	6.55e-06	8.31e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCL2—coronary artery disease	6.54e-06	8.29e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6R—coronary artery disease	6.52e-06	8.26e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APOA1—coronary artery disease	6.5e-06	8.24e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SDC1—coronary artery disease	6.48e-06	8.22e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—JAK2—coronary artery disease	6.46e-06	8.19e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KDR—coronary artery disease	6.44e-06	8.16e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IGF1—coronary artery disease	6.43e-06	8.15e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAPK14—coronary artery disease	6.4e-06	8.11e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—MAPK1—coronary artery disease	6.4e-06	8.11e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TXNRD1—coronary artery disease	6.37e-06	8.07e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP11B2—coronary artery disease	6.37e-06	8.07e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PIK3CA—coronary artery disease	6.33e-06	8.02e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ESR1—coronary artery disease	6.27e-06	7.96e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC22A3—coronary artery disease	6.27e-06	7.95e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—F2—coronary artery disease	6.2e-06	7.86e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FN1—coronary artery disease	6.2e-06	7.86e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HADH—coronary artery disease	6.18e-06	7.84e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ARNTL—coronary artery disease	6.18e-06	7.84e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6ST—coronary artery disease	6.17e-06	7.83e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NFKBIA—coronary artery disease	6.12e-06	7.76e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PSMB5—coronary artery disease	6.12e-06	7.76e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PSMA6—coronary artery disease	6.12e-06	7.76e-05	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PIK3CA—coronary artery disease	6.11e-06	7.75e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SERPINE1—coronary artery disease	6.1e-06	7.74e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CTGF—coronary artery disease	5.98e-06	7.58e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KIT—coronary artery disease	5.93e-06	7.52e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HMGCR—coronary artery disease	5.93e-06	7.51e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GOT2—coronary artery disease	5.93e-06	7.51e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FGF2—coronary artery disease	5.91e-06	7.49e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCL8—coronary artery disease	5.89e-06	7.47e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOA2—coronary artery disease	5.86e-06	7.43e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	5.86e-06	7.43e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GPX2—coronary artery disease	5.86e-06	7.43e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NOS3—coronary artery disease	5.83e-06	7.39e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HK1—coronary artery disease	5.79e-06	7.34e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SULT1A1—coronary artery disease	5.79e-06	7.34e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GPX4—coronary artery disease	5.79e-06	7.34e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCG5—coronary artery disease	5.79e-06	7.34e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HADHA—coronary artery disease	5.72e-06	7.25e-05	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—AKT1—coronary artery disease	5.69e-06	7.22e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GSK3B—coronary artery disease	5.69e-06	7.22e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—JAK2—coronary artery disease	5.66e-06	7.18e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTA1—coronary artery disease	5.65e-06	7.17e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—POMC—coronary artery disease	5.65e-06	7.16e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CREB1—coronary artery disease	5.65e-06	7.16e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CASP3—coronary artery disease	5.64e-06	7.15e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL6—coronary artery disease	5.6e-06	7.1e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LPA—coronary artery disease	5.59e-06	7.09e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PIK3CA—coronary artery disease	5.55e-06	7.04e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCL2—coronary artery disease	5.52e-06	7e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6R—coronary artery disease	5.51e-06	6.98e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCND1—coronary artery disease	5.49e-06	6.96e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PLCB1—coronary artery disease	5.45e-06	6.91e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IGF1—coronary artery disease	5.43e-06	6.89e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PLCB3—coronary artery disease	5.41e-06	6.86e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—MAPK1—coronary artery disease	5.4e-06	6.85e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOA5—coronary artery disease	5.36e-06	6.8e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MMP9—coronary artery disease	5.33e-06	6.76e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ABCA1—coronary artery disease	5.28e-06	6.7e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—P4HB—coronary artery disease	5.26e-06	6.66e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—AKT1—coronary artery disease	5.17e-06	6.55e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCL8—coronary artery disease	5.17e-06	6.55e-05	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	5.16e-06	6.55e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	5.16e-06	6.54e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SERPINE1—coronary artery disease	5.16e-06	6.54e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GGT1—coronary artery disease	5.12e-06	6.49e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GOT1—coronary artery disease	5.12e-06	6.49e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FGF2—coronary artery disease	4.99e-06	6.33e-05	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—AKT1—coronary artery disease	4.99e-06	6.33e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CASP3—coronary artery disease	4.95e-06	6.27e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOS3—coronary artery disease	4.92e-06	6.24e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL6—coronary artery disease	4.91e-06	6.23e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—VCAN—coronary artery disease	4.86e-06	6.17e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALDOA—coronary artery disease	4.83e-06	6.12e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCND1—coronary artery disease	4.81e-06	6.1e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—VEGFA—coronary artery disease	4.79e-06	6.07e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—JAK2—coronary artery disease	4.79e-06	6.07e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CA—coronary artery disease	4.69e-06	5.95e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—DCN—coronary artery disease	4.68e-06	5.94e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MMP9—coronary artery disease	4.67e-06	5.93e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTP1—coronary artery disease	4.6e-06	5.83e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALDH2—coronary artery disease	4.56e-06	5.78e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	4.55e-06	5.77e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—AKT1—coronary artery disease	4.53e-06	5.75e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HMOX1—coronary artery disease	4.53e-06	5.75e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CAT—coronary artery disease	4.47e-06	5.67e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LIPC—coronary artery disease	4.44e-06	5.63e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HBA1—coronary artery disease	4.44e-06	5.63e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	4.44e-06	5.63e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP2C19—coronary artery disease	4.44e-06	5.63e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOC3—coronary artery disease	4.41e-06	5.6e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TGFB1—coronary artery disease	4.39e-06	5.57e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LDLR—coronary artery disease	4.39e-06	5.56e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCL8—coronary artery disease	4.37e-06	5.54e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOB—coronary artery disease	4.34e-06	5.5e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC9A1—coronary artery disease	4.33e-06	5.5e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTT1—coronary artery disease	4.33e-06	5.5e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAPK1—coronary artery disease	4.31e-06	5.46e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GCLC—coronary artery disease	4.28e-06	5.43e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CETP—coronary artery disease	4.28e-06	5.43e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SDC1—coronary artery disease	4.24e-06	5.37e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTM1—coronary artery disease	4.22e-06	5.35e-05	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—AKT1—coronary artery disease	4.22e-06	5.35e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—VEGFA—coronary artery disease	4.2e-06	5.32e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CASP3—coronary artery disease	4.18e-06	5.3e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL6—coronary artery disease	4.15e-06	5.27e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—LPL—coronary artery disease	4.15e-06	5.26e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCND1—coronary artery disease	4.07e-06	5.16e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GPX1—coronary artery disease	4.04e-06	5.13e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PSMA6—coronary artery disease	4e-06	5.07e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PSMB5—coronary artery disease	4e-06	5.07e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MMP9—coronary artery disease	3.95e-06	5.01e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CD36—coronary artery disease	3.94e-06	4.99e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CTGF—coronary artery disease	3.91e-06	4.96e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PPP2CA—coronary artery disease	3.89e-06	4.93e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GOT2—coronary artery disease	3.87e-06	4.91e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HMGCR—coronary artery disease	3.87e-06	4.91e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TGFB1—coronary artery disease	3.85e-06	4.88e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—AKT1—coronary artery disease	3.83e-06	4.86e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAPK1—coronary artery disease	3.78e-06	4.79e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CA—coronary artery disease	3.74e-06	4.74e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MTHFR—coronary artery disease	3.73e-06	4.73e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PLCB1—coronary artery disease	3.56e-06	4.52e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—VEGFA—coronary artery disease	3.55e-06	4.5e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AGT—coronary artery disease	3.55e-06	4.5e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOE—coronary artery disease	3.47e-06	4.41e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCA1—coronary artery disease	3.45e-06	4.38e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOA1—coronary artery disease	3.43e-06	4.35e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GOT1—coronary artery disease	3.34e-06	4.24e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GGT1—coronary artery disease	3.34e-06	4.24e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6—coronary artery disease	3.31e-06	4.2e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CA—coronary artery disease	3.28e-06	4.16e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TGFB1—coronary artery disease	3.26e-06	4.13e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAPK1—coronary artery disease	3.19e-06	4.05e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AKT1—coronary artery disease	3.05e-06	3.87e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PPARG—coronary artery disease	3.03e-06	3.84e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTP1—coronary artery disease	3e-06	3.81e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—POMC—coronary artery disease	2.98e-06	3.78e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.98e-06	3.77e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.96e-06	3.76e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CAT—coronary artery disease	2.92e-06	3.71e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6—coronary artery disease	2.9e-06	3.68e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOB—coronary artery disease	2.84e-06	3.6e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CA—coronary artery disease	2.77e-06	3.51e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.76e-06	3.5e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALB—coronary artery disease	2.72e-06	3.45e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LPL—coronary artery disease	2.71e-06	3.44e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AKT1—coronary artery disease	2.68e-06	3.4e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GPX1—coronary artery disease	2.64e-06	3.35e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NOS3—coronary artery disease	2.6e-06	3.3e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CD36—coronary artery disease	2.58e-06	3.26e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.54e-06	3.22e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6—coronary artery disease	2.45e-06	3.11e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.44e-06	3.09e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PTGS2—coronary artery disease	2.38e-06	3.02e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AGT—coronary artery disease	2.32e-06	2.94e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOE—coronary artery disease	2.27e-06	2.88e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AKT1—coronary artery disease	2.26e-06	2.87e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOA1—coronary artery disease	2.25e-06	2.85e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPARG—coronary artery disease	1.98e-06	2.51e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—POMC—coronary artery disease	1.95e-06	2.47e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALB—coronary artery disease	1.78e-06	2.26e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NOS3—coronary artery disease	1.7e-06	2.16e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.56e-06	1.97e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.46e-06	1.86e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AKT1—coronary artery disease	1.2e-06	1.52e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CA—coronary artery disease	9.58e-07	1.21e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AKT1—coronary artery disease	7.82e-07	9.92e-06	CbGpPWpGaD
